•  
  •  
  •  
  •  

2025-10-07 21:46:17

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain

Keywords Selected:  660MW

Stock Report

  • THDC India Ltd commissions Unit 2 of 660 MW of Khurja STPP
  • NTPC declares commercial operation of Unit 3 of North Karanpura Super Thermal Power Project
  • NTPC completes trial operation of 660 MW capacity unit of BARH Super Thermal Power Project, Stage-1
  • NTPC commissions Unit-3 for 660 MW capacity of North Karanpura Super Thermal Power Project
  • NTPC's total capacity increases to 75858 MW
  • NTPC declares COD of second unit of 660 MW capacity of Barh Super Thermal Power Station, Stage-I
  • BHEL successfully synchronises 660 MW unit of Maitree Super Thermal Power Project in Bangladesh
  • NTPC completes trial operation by 660 MW capacity unit of Barh Super Thermal Power Project
  • NTPC commissions Unit-1 of 660 MW of Barh Super Thermal Power Project

Latest Post

  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024